Anti-aging skincare has traditionally focused on measurable signs such as wrinkles, firmness, elasticity, pigmentation and hydration. These endpoints remain important, but the development conversation is becoming broader.
The Global Wellness Summit included Skin Longevity Redefines Beauty among its 2026 trends, reflecting growing interest in maintaining skin health and resilience over time rather than focusing only on correcting visible signs of aging (Global Wellness Summit, 2026).
For the cosmetic industry, the more important question is what this change means for active ingredient and formulation development.
Skin Longevity vs. Traditional Anti-Aging
Traditional anti-aging development often starts with a visible concern and works backward to an ingredient.
Wrinkles may lead to collagen-related strategies. Loss of firmness may lead to extracellular matrix support. Dryness may lead to barrier and moisturization systems. Pigmentation may lead to melanogenesis-related targets.
Skin longevity takes a longer view.
Skin aging results from intrinsic biological aging together with cumulative environmental exposure. UV radiation, pollution and other components of the exposome interact with oxidative stress, inflammation, cellular function and extracellular matrix remodeling throughout the aging process (Furman et al., 2025).
As a result, skin quality becomes a broader development target. Barrier integrity, hydration, dermal structure and the ability to cope with repeated environmental stress all contribute to how skin changes over time.
The difference is therefore less about replacing one category with another and more about extending the development time frame beyond a single visible endpoint.
Why Long-Term Skin Condition Is Attracting Attention
Skin is exposed to environmental stress every day. UV radiation, oxidative stress and pollution accumulate alongside intrinsic aging, making resilience an increasingly relevant consideration.
Many established ingredient functions already fit this approach. Antioxidants address oxidative stress, barrier-supporting ingredients help maintain epidermal function, and collagen- or extracellular-matrix-related actives target structural changes.
What is changing is the way these functions are evaluated. Instead of asking only whether an active improves one visible parameter, developers may also consider how its biological activity relates to maintaining skin condition during repeated exposure and continued use.
This also brings long-term tolerability into the formulation discussion. A product designed for ongoing skin maintenance needs to perform within a routine that can be used consistently.
What Current Skin Aging Research Is Exploring
Current skin-aging research has expanded beyond collagen loss to oxidative stress, mitochondrial function, cellular senescence, inflammation and extracellular matrix changes (Furman et al., 2025). This broader scope is also influencing how cosmetic actives are being studied: researchers are beginning to examine whether an ingredient relates to multiple biological processes involved in skin condition rather than only one visible anti-aging endpoint.
Pterostilbene’s recent research reflects this direction. Zhong et al. (2025) studied Pterostilbene in UVA-exposed sebocytes and fibroblasts. The researchers observed reduced ROS levels in both models, together with increased lipid synthesis in sebocytes and increased collagen I and III in fibroblasts. Pterostilbene also affected F-actin distribution. The study therefore extends beyond a simple antioxidant assessment to include oxidative stress, sebaceous gland function and cellular responses related to skin structure.
Human data provide another layer of evidence. Cen et al. (2025) evaluated a 0.1% Pterostilbene emulsion in a 28-day double-blind, split-face clinical study involving 31 participants. The treatment showed improvements in instrumental measurements related to elasticity, firmness, wrinkles, epidermal thickness and collagen- and elastic-fiber-related parameters.
These studies connect Pterostilbene with both conventional anti-aging research and the broader discussion around maintaining skin condition over time. However, the current evidence is not sufficient to define Pterostilbene as a Skin Longevity ingredient or to demonstrate an extension of the functional lifespan of human skin.
For active ingredient development, the more important change is the expansion of evaluation dimensions. Antioxidant, barrier-supporting, collagen-related and extracellular-matrix functions remain established areas of research, but future development may place greater emphasis on how these biological activities connect with actual skin outcomes and whether mechanism studies, formulation performance and human data can form a coherent evidence base.
Where Skin Longevity May Influence Formulation Development
The practical impact of the longevity trend is likely to appear in existing anti-aging formulations rather than through an entirely new product format.
A firming formula may still target collagen and elasticity while giving greater consideration to barrier condition and repeated-use tolerance. A brightening product may continue to address pigmentation while accounting for irritation and long-term barrier maintenance.
For active ingredient development, formulation evaluation may also extend beyond a single efficacy endpoint to include stability, compatibility, use concentration and long-term tolerability. Whether an ingredient can remain stable within a practical formulation system and support consistent use may become increasingly important as product development takes a longer-term view of skin health.
The trend therefore does not create a completely new formulation rule. It places greater emphasis on connecting ingredient activity, formulation performance and sustained use.
How Will Skin Longevity Be Measured?
Skin Longevity is not replacing Anti-Aging. It is broadening the time frame through which skin performance is considered.
Wrinkles, firmness, elasticity, pigmentation and hydration remain measurable cosmetic outcomes. At the same time, ingredient development is beginning to pay more attention to the biological and structural conditions underlying those outcomes.
Pterostilbene illustrates this transition: its conventional anti-aging research is now accompanied by studies covering oxidative stress, sebocyte activity, fibroblast responses and structural parameters. Whether this broader research profile can eventually support claims around long-term skin health will depend on stronger formulation and human evidence.
The more important industry question may therefore be how future active ingredient research defines and measures sustained skin performance, rather than simply how many ingredients can be placed under the “longevity” label.
References
- Furman, D., Auwerx, J., Bulteau, A.-L., et al. (2025). Skin health and biological aging. Nature Aging, 5, 1195–1206.
https://doi.org/10.1038/s43587-025-00901-6 - Zhong, Y., Wang, Q., Wang, Y., Ye, R., Du, L., & Hu, F. (2025). Pterostilbene: A natural compound for anti-ageing in sebaceous gland cells and fibroblasts. International Journal of Cosmetic Science, 47(5), 902–915.
https://doi.org/10.1111/ics.13078 - Cen, Z., Chen, Z., Wang, D., Zuo, Y., Chen, J., & Chen, X. (2025). Anti-aging efficacy of a 0.1% Pterostilbene skincare emulsion: A 28-day clinical trial. Journal of Dermatologic Science and Cosmetic Technology, 2(2), 100083.
https://doi.org/10.1016/j.jdsct.2025.100083 - Global Wellness Summit. (2026). The Future of Wellness 2026: Skin Longevity Redefines Beauty. Global Wellness Summit.
English
German
Spanish
French
Japanese
Korean